PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Funding for ATL1103 Phase II Trial and Pipel, page-18

  1. 3,080 Posts.
    lightbulb Created with Sketch. 574
    re: Ann: Funding for ATL1103 Phase II Trial a... Would be very nice to see gains here on ANP like PRR saw, then look at it proportionally to number of products and value or gains in the product and we could easily be sitting on a multi multi bagger.

    Go ANP, its only a matter of time for us IMO.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.